Match Document Document Title
DE10226203A1 Condensed palatinose and processes for their preparation  
The invention relates to a novel palatinose condensation product obtained by condensation of the disaccharide palatinose in a melt of palatinose, water and an organic acid.
DE20121979U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121977U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121974U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121973U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121972U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121971U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121970U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121969U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121965U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10325815A1 New variant DNA sequence, useful for diagnosis of e.g. defecation disorders and thyroid carcinoma, is derived from the promoter region of the human RET proto-oncogene  
DNA sequence (I) that comprises the -1 to -30 region of the 5'-untranslated region (UTR) of the human RET proto-oncogene and includes the variations A at -1 to T, C or G and/or G at -5 to T, C or...
DE10226367A1 Ganglioside mit modifizierter Acylfunktion  
Bereitgestellt wird eine Gangliosidmischung, die Ganglioside der folgenden allgemeinen Formel I: DOLLAR A (Zucker)-OCH¶2¶-CH(-NH-CO-R·1·)-CH(OH)-CH=CH-R·2·, DOLLAR A worin DOLLAR A (Zucker) für...
DE10225705A1 Banderolierung von Banknoten  
Die Erfindung betrifft einen Banderolierer für Banknoten und eine Banknotenbearbeitungsvorrichtung mit einem solchen Banderolierer. DOLLAR A Ein besonders sicheres und schnelles Banderolieren ist...
DE10225628A1 CDG-Therapie mit Mannose  
Bereitgestellt werden Mannose 1-Phosphat Derivate und diese enthaltende pharmazeutische oder diätetische Mittel zur Behandlung von Glykosylierungsstörungen und insbesondere zur Behandlung von...
DE20121968U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121967U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121963U1 Nucleic acids for diagnosis of diseases associated with developmental genes  
Nucleic acid of genes that are associated with the development, comprising an at least 18 base long sequence segment of the chemically pretreated DNA of one of the sequences selected from the...
DE20121961U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10224624A1 Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol  
Die Erfindung betrifft die Verwendung von 1-Phenyl-3-dimethylaminopropanverbindungen zur Herstellung eines Arzneimittels zur Behandlung von vermehrtem Harndrang bzw. Harninkontinenz sowie...
DE10223057A1 Verfahren zur Erzeugung von Polynukleotidmolekülen  
Die Erfindung betrifft Verfahren zur Erzeugung von Polynukleotidmolekülen mit veränderten Eigenschaften, wobei mindestens ein Zyklus, umfassend die folgenden Schritte durchlaufen wird: DOLLAR A...
DE10222632A1 Mikrosatellitenmarker für genetische Analysen und zur Unterscheidung von Rosen  
Mikrosatelliten aus Pflanzen der Gattung Rosa, einschließlich den isolierten Mikrosatelliten, Primern aus flankierenden Regionen der Mikrosatelliten, ein Verfahren zur Herstellung der...
DE10221004A1 Detection of oligonucleotide hybridization comprises electrochemically detecting reduction and/or oxidation of a redox-active species  
Detection of oligonucleotide hybridization comprises binding uncharged oligonucleotide molecules to a surface, contacting the surface with a solution of a redox-active species, contacting the...
DE10220799A1 Verfahren zur Herstellung von C13-Alkoholgemischen  
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung eines C¶13¶-Alkoholgemisches, das insbesondere als Vorstufe für die Herstellung von Verbindungen mit tensidischen Eigenschaften und...
DE10222858A1 Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien  
Die Erfindung betrifft Verfahren zur fermentativen Herstellung von schwefelhaltigen Feinchemikalien, insbesondere L-Methionin, unter Verwendung von Bakterien, in denen eine für ein...
DE10222133A1 Verfahren zur Nukleinsäure-Extraktion und Nukleinsäure-Reinigung  
Die vorliegende Erfindung betrifft die Verwendung von multivalenten Kationen und komplexbildenden Agenzien zur Nukleinsäure-Extraktion und Nukleinsäure-Reinigung mit Trägermaterialien auf...
DE10221836A1 Attenuierung von Metapneumovirus  
Die vorliegende Erfindung betrifft einen Impfstoff gegen Mitglieder der Gattung Metapneumovirus oder RSV oder ein Virus, das eine bedeutende genetische Homologie im F-Protein zu Mitgliedern der...
DE10222494A1 Parallel recovery of RNA and protein from tissue, useful e.g. for diagnosis of tumors, by treating sample with RNAlater solution, homogenizing and separating epithelial cells  
Parallel recovery of RNA and protein comprising first treating a resected tissue sample with a preparation solution containing RNAlater (RTM) at 40-100 g/100 ml, mechanically disintegrating the...
DE10221091A1 SECM zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen  
Beschrieben wird ein Verfahren zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen, das die Schritte Bereitstellen einer modifizierten Oberfläche, wobei die Modifikation in der...
DE10220894A1 Promotoren mit veränderter Transkriptionseffizienz  
Die vorliegende Erfindung betrifft eine Desoxyribonukleinsäure (DNA), umfassend mindestens eine Promotorsequenz, die von einem Wildtyp-Promotor einer methylotrophen Hefe abgeleitet ist, deren...
DE20121966U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10220188A1 New antagonists of calcitonin gene-related peptide or amylin, useful for treating or preventing e.g. migraine or inflammation, are specific binding nucleic acids  
An antagonist (I) of CGRP (calcitonin gene-related peptide), especially a nucleic acid, preferably one that binds to CGRP, is new. Independent claims are also included for: (1) antagonist (Ia) of...
DE10218554A1 Syringe for purifying liquid or isolating substances from it, especially nucleic acids or proteins from blood, plasma or urine, has filter above its inlet, on which purifying agent is placed  
Syringe (12) for purifying a liquid and/or isolating substances from it has a filter (26) positioned above its inlet/outlet (24). Purifying agent (28) is placed on the filter on the side opposite...
DE10218476A1 Medicaments, cosmetics and dermatological compositions for a wide variety of skin treatments contain lignans or their glycosides  
Cosmetic and/or dermatological compositions contain lignans (or their glycosides) in addition to conventional ingredients.
DE10217994A1 A coupling product from (sic) chemical compounds of hyperbranched polysaccharide completely catabolized in the body under control of the body enzymes useful for parenteral pharmaceutically active materials  
A coupling product from (sic) chemical compounds of (sic) hyperbranched polysaccharide, i.e. from alpha-1,4-glycoside linked anhydroglucose units with alpha-1,6-glycosidal branching anhydroglucose...
DE10216426A1 Beta-L-2'-deoxy-thymidine preparation, for use as antiviral agent, from L-arabinose in 4-stage process via new oxazolidine derivative and thymidine derivative intermediates  
Preparation of beta-L-2'-deoxy-thymidine (I) involves: (a) reacting L-arabinose with cyanamide and optionally protecting the product; (b) reacting the obtained oxazoline compound (II) with a...
DE10214395A1 Parallel sequencing of nucleic acid segments, useful for detecting single-nucleotide polymorphisms, by single-base extensions with labeled nucleotide  
Parallel sequence analysis of segments of a complete nucleic acid sequence, using sequence-specific primers, is new. Parallel sequence analysis of segments of a complete nucleic acid sequence,...
DE10212397A1 Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie  
Offenbart werden Polypeptidsequenzen, die in der Regulation der Skelettmuskeldifferenzierung eine Rolle spielen sowie dafür kodierende Nukleinsäuren und deren Verwendung in Diagnostik und...
DE10248451A1 Fredericamycin-Derivate  
Die Erfindung betrifft neue Fredericamycin-Derivate, Arzneimittel, die diese oder deren Salze enthalten, und die Verwendung der Fredericamycin-Derivate zur Behandlung von Erkrankungen,...
DE20303420U1 Fischer-Tropsch and corresponding Guerbet alcohol mixtures, derivatives and compositions are useful e.g. in polymer, oil, cosmetic, pharmaceutical, detergent or functional fluid containing polymer surfactant and/or hydraulic fluid  
Alcohol mixtures (I) comprising Fischer-Tropsch alcohols and derivatives comprise alcohols containing (wt.%): (a) over 20% to 80% primary alcohols with a linear aliphatic chain; (b) over 10% to...
DE10209203A1 Composition useful for preparing DNA chips comprises compound with labile functional group and a sensitizer that acts by triplet-triplet energy transfer  
Chemical composition (A) comprises a molecule (I) having a labile functional group (LFG) and a compound (II) that has a triplet state energy higher than, or very close to, that of LFG. An...
DE10209071A1 Standardized polynucleotide system, useful for quantitative, real-time determination of nucleic acid, comprises stabilized standards, primers and probe  
Standardized polynucleotide system (A) comprises at least one carrier nucleic acid (cNA); at least 3 oligonucleotides (ON), as primers and target-specific, fluorescently labeled probe; optionally...
DE10210527A1 Allele des aceA-Gens aus coryneformen Bakterien  
Die Erfindung betrifft Allele aceA-Gens aus coryneformen Bakterien, kodierend für Isocitrat-Lyasen, und Verfahren zur fermentativen Herstellung von L-Lysin unter Verwendung von Bakterien, die...
DE10209564A1 Antitumoral and antineoplastic medicaments, effective against carcinoma, sarcoma, lymphoma and leukemia, comprise new or known nucleoside-sulfur containing phospholipid derivatives  
Nucleoside-sulfur containing phospholipid derivatives (I), which on adminstration to humans directly or indirectly provide (I) or other antitumoral or antiproliferative active metabolites or their...
DE10159264A1 Verwendung von Acetoacetyl-CoA Thiolase zum Identifizieren von neuen fungizid wirksamen Substanzen  
Die Erfindung betrifft Nukleinsäuren, die für Polypeptide aus Pilzen mit der biologischen Aktivität von Acetoacetyl-CoA-Thiolase kodieren, die davon kodierten Polypeptide sowie deren Verwendung...
DE10232507C1 Sequence-controlled synthesis of nucleic acids, useful for making synthetic genes, comprises hybridizing primers to both strands then filling in gaps using a nucleic acid polymerase system  
Sequence-controlled preparation of a nucleic acid product (NP), comprising hybridizing primers to both strands then filling in gaps using a nucleic acid polymerase system, is new....
DE10206845A1 Surfactant alcohols and their ethers are obtained by a modified process involving metathesis of an olefin mixture, followed by dimerization and derivatization  
Production of surfactant alcohols or their ethers by derivatization of 10-20C olefins or mixtures, comprises: (i) metathesizing a 4C olefin mixture; (ii) removing the 5-8C olefins; (iii)...
DE20308345U1 Injection solution, for use in pyrosequencing equipment, comprises a buffer, deoxynucleotide and an alkaline pH which permits longer sequencing  
An injection solution for use in pyrosequencing equipment comprises: (1) a deoxynucleotide; (2) a buffer; and (3) an alkaline pH which permits longer sequencing, is new.
DE10205607A1 New nucleic acid encoding fatty acid elongase, useful for producing polyunsaturated fatty acids as oils, lipids or free fatty acids  
Isolated nucleic acid (I) that encodes a polypeptide (II) able to extend 16 or 18 carbon fatty acids having at least two double bonds by at least 2 carbon atoms, where the fatty acids...
DE10205500A1 Dyeing of hair in intense orange and red-gold to violet shades uses a mixture of a hydrolysate-containing preparation with 1,2,4-trihydroxynaphthalene glycoside (i.e. Lawson) derivative dye carriers, some of which are new  
A composition for dyeing keratinous fibers is obtained by mixing directly before use (A) a dye carrier containing a 1,2,4-trihydroxynaphthalene glycoside (i.e. Lawson) derivative and (B) a...
DE10204843A1 New nucleic acid from Arabidopsis thaliana, useful e.g. for detecting the presence or expression of corresponding genes, involved in metabolism and detoxification  
Nucleic acid (I) for qualitative or quantitative detection of Arabidopsis thaliana genes, or fragments, or derived RNA, comprises one of 275 fully defined sequences given in the specification, or...